Effects Of Instrument Assisted Soft Tissue Mobilization on Pain, Grip Strength and Functional Activity in Patients With Lateral Epicondylitis
1 other identifier
interventional
72
1 country
1
Brief Summary
This study aimed to find the effects of Instrument Assisted Soft Tissue Mobilization (IASTM) using Ergon Tools on pain, grip strength and functional activity among patients diagnosed with Lateral epicondylitis. The study concluded that IASTM is effective in improving pain, grip strength and functional activity in patients with lateral epicondylitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 26, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedJanuary 26, 2023
January 1, 2023
7 months
November 26, 2022
January 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain (mild to severe)
Visual Analogue Scale The score is calculated by measuring the distance (mm) between the "no pain" anchor and the patient's mark on a 10-cm line with a ruler, yielding a range of 0-100. A higher score implies that the pain is more intense and a lower score suggests the intensity of pain to be milder. VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain
4 weeks
Grip Strength
Digital Hand Held Dynamometer The best result from several trials for each hand is recorded, with at least 15 seconds recovery between each effort. The values listed below (in kg and lbs) give a guide to expected scores for adults. These values are the average of the best scores of each hand. See more Hand Grip Strength Norms. Other protocols will just use the score from the dominant hand, or compare the left and right hand results. See also examples of some actual athlete results.
4 weeks
Functional Activity
Patient Rated Tennis Elbow Evaluation It consists of pain subscale and functional subscale, total score is calculated by adding Pain Subscale and Function Subscale then calculated as, Best Score= 0 Worst Score = 100 (pain and disability contribute equally to score)
4 weeks
Study Arms (2)
Conventional Physcial Therapy Group
ACTIVE COMPARATORAll participants received treatment 2 times a week for 4 weeks. Pre-treatment included a Moist hot pack for 10 minutes and traditional physical therapy included Cyriax Deep Friction Massage (DFM), Ultrasound therapy as well as strengthening and stretching exercises
IASTM Group
EXPERIMENTALParticipants received Instrument Assisted Soft Tissue Mobilization Treatment 2 times a week for 4 weeks using Ergon IASTM tools.
Interventions
Tools designed for soft tissue mobilization
Moist Hot pack, Ultrasound, Deep Friction Massage, Stretching and Strengthening Exercises.
Eligibility Criteria
You may qualify if:
- Both Male and Female Patients
- Patients between the age group 20-50 years
- Sub-acute Patients having symptoms for \> 6 weeks and \< 3 months.
- Patients who had pain rating from 5 to 9 in VAS will be included
- Patients with Positive Cozens test, Mill's test
You may not qualify if:
- Patients with any surgical or trauma history of the elbow
- Rheumatoid Arthritis and Malignancies
- Cervical Radiculopathy patients who have referred pain in the elbow
- Loss of Passive ROM in extension
- Active infections such as, Bursitis, Calcification of the soft tissues, Fragile skin, Hyper Mobility \& Joint Effusion
- Hemophilic Patients
- Osteoporosis
- Patients with history of getting treatment with Steroid Injections will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sikander Medical Complex
Gujranwala, Pujab, 52250, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shazal Nazir, DPT
University of Lahore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The study was single-blinded as the assessor was blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2022
First Posted
January 26, 2023
Study Start
March 1, 2022
Primary Completion
September 30, 2022
Study Completion
November 1, 2022
Last Updated
January 26, 2023
Record last verified: 2023-01